Clinical Trials Directory

Trials / Sponsors / Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Industry · 13 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Trial to Evaluate the Effect of CD388 on the Immunogenicity of Fluzone® HD Vaccine
Healthy Participants
Phase 12025-11-08
Active Not RecruitingA Study to Evaluate the Safety, Pharmacokinetics, and Occurrence of Anti-Drug Antibodies Following Annual Dose
Healthy Participants
Phase 22025-10-29
Active Not RecruitingA Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
Influenza
Phase 32025-09-25
CompletedStudy of CD388 for the Prevention of Influenza in Subjects Not at Risk for Influenza Complications
Influenza
Phase 22024-09-20
CompletedStudy of CD388 Subcutaneous Administration in Healthy Japanese Subjects
Healthy
Phase 12022-10-18
CompletedThe Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
Influenza
Phase 22022-09-09
CompletedStudy of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects
Healthy
Phase 12022-03-14
CompletedStudy of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis
Candidemia, Mycoses, Fungal Infection
Phase 32018-10-07
CompletedNon-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
Candidiasis, Vulvovaginal, Yeast Infection, Mycoses
—2016-08-16
CompletedCD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidias
Candidemia, Mycoses, Fungal Infection
Phase 22016-07-26
CompletedRADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
Candidiasis, Vulvovaginal, Mycoses, Yeast Infection
Phase 22016-06-08
CompletedAn Ascending Multiple Dose Study of CD101 IV in Healthy Subjects
Healthy
Phase 12015-09-01
CompletedA Single Ascending Dose Study of CD101 IV in Healthy Subjects
Healthy
Phase 12015-07-01